Science Explorer Back to mapMap
Discussion
Researcher · Institut National d'Oncologie · Morocco

H. Bakkali

H. Bakkali publishes mostly in Surgery, Obstetrics and Gynecology and Epidemiology, on topics such as Endometrial and Cervical Cancer Treatments, Breast Cancer Treatment Studies and Ovarian cancer diagnosis and treatment.

OpenAlex
World rank
#6,013,333
of 7,710,434 ranked researchers
Rank in Morocco
#8,367
of 14,526
Works
23
Citations
167
Citations per work
7.3
h-index
5
i10-index 2Top 83% in Surgery
H. Bakkali

What does H. Bakkali research?

H. Bakkali's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 13 works · 56.4% of their workMedicine: 13 works · 56.4% of their workSurgery: 4 works · 18.8% of their workObstetrics and Gynecology: 3 works · 14.5% of their workEpidemiology: 2 works · 8.7% of their workOncology: 2 works · 7.2% of their workReproductive Medicine: 2 works · 7.2% of their workEverything else: 8 works · 36.4% of their workLife Sciences: 2 works · 7.2% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 7.2% of their workCancer Research: 2 works · 7.2% of their workTHEIR WORKH. Bakkali23works
Life Sciences7%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1356.4%
  2. Everything else836.4%
    1. Biochemistry, Genetics and Molecular Biology27.2%
  1. 1Surgery19% of their works
  2. 2Obstetrics and Gynecology14% of their works
  3. 3Epidemiology9% of their works
  4. 4Oncology7% of their works
  5. 5Reproductive Medicine7% of their works
  6. 6Cancer Research7% of their works

Research topics

Which keywords describe H. Bakkali's research?

The keywords of their largest research topics: Clinical Practice Guidelines, Survival Analysis, Cervical Cancer, Chemotherapy, Brachytherapy, Endometrial Carcinoma, Radiotherapy and Breast Tumours.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Clinical Practice Guidelines152 topics
  2. Survival Analysis152 topics
  3. Cervical Cancer122 topics
  4. Chemotherapy113 topics
  5. Brachytherapy101 topic
  6. Endometrial Carcinoma101 topic
  7. Radiotherapy82 topics
  8. Breast Tumours51 topic
  9. Gene Expression51 topic
  10. Genomic Analysis51 topic
  11. Human Papillomavirus52 topics
  12. Ovarian Cancer51 topic
  13. Cancer Incidence42 topics
  14. Anal Cancer31 topic
  15. Chemoradiation31 topic
  16. Oropharyngeal Cancer31 topic
  17. Squamous Cell Carcinoma31 topic
  18. Epidemiology21 topic
  19. HPV Vaccination21 topic
  20. Multiple Primary Cancers21 topic
  21. Second Primary Neoplasms21 topic
  22. VEGF21 topic
  23. endothelial progenitor cells21 topic

Where does H. Bakkali work?

H. Bakkali's main affiliation in the publication record is Institut National d'Oncologie, Morocco.

How many publications and citations does H. Bakkali have?

OpenAlex counts 23 works and 167 citations for H. Bakkali, an h-index of 5, ranking #6,013,333 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about H. Bakkali. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.